Clinical Trials Unit
Stanford University School of Medicine's Center for Advanced Dermatologic Investigation is the Dermatology Department's clinical trials unit.
The Center is home to 12-15 ongoing clinical studies, investigating the safety and efficacy of new and currently available drugs and over-the-counter medications. The Center works with Stanford's own panel on medical research, leading pharmaceutical companies,and the Food and Drug Administration to safely and ethically expand the medical field's knowledge of dermatologic treatments. New studies begin regularly, and the Center continues to recruit patients with skin aging, sun damage, skin cancer (including basal cell carcinomas), psoriasis, atopic dermatitis, rosacea, and other dermatologic diseases for ongoing studies.
Skin Aging Studies
We seek to understand the human aging processes as it relates to skin on a fundamental level. To this end, our studies focus on clinical and translational research efforts ranging from: (1) the analysis of gene changes which predispose individuals to exceptionally youthful skin to (2) molecular signatures that may be biomarkers for aging skin to (3) the careful study of new candidate agents which might affect the skin aging process.
Nonmelanoma Skin Cancer
Recent advances in our understanding of basal cell skin cancer biology have enabled the development of cutting edge study drugs which combat tumor growth. We are currently home to a number of clinical trials at the forefront of potential therapy for advanced or metastatic basal cell cancer. In addition, we seek to understand the biology of basal cell skin cancers and to identify molecular predictors for treatment success.
Acne Rosecea
This is a common and frustrating chronic inflammatory condition of the face, usually affecting older individuals. The causes of this complex condition are the subject of much study. Our clinical studies seek to identify new topical or oral medications to improve the symptoms of acne rosacea.
Contact
For more information, please email dermtrials@stanford.edu
Featured Clinical Trials
The Impact of Pediatric Skin Disorders: The "Big" Study
This study leverages the availability of a validated series of instruments to measure the effect of highly visible, chronic skin disorders, including atopic dermatitis (AD), on patients 8 years of age and above in causing stigma and psychiatric issues, particularly anxiety and depression.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Eligibility
Inclusion Criteria:
* Subjects must be aged 8-17 years of age
* Subject must be diagnosed with a chronic skin disease deemed to be severe enough and/or in a visible location that could be stigmatizing as determined by the study doctor
* Subject and parent must both be English speaking with at least one parent/guardian who will complete the questionnaires
* Subject and Parent/Guardian must be able to complete the relevant questionnaires
Exclusion Criteria:
* Children under 8 years of age
* Children with developmental delay and/or a behavioral disorder that would preclude participation in form completion
* Children with a non-cutaneous disorder that is considered by the Study doctor to be stigmatizing
Ages Eligible for Study
8 Years - 17 Years
Genders Eligible for Study
ALL
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Pediatric Dermatology Study
650-723-0636
Not Recruiting
Psoriasis Clinical Trials
The Impact of Pediatric Skin Disorders: The "Big" Study
This study leverages the availability of a validated series of instruments to measure the effect of highly visible, chronic skin disorders, including atopic dermatitis (AD), on patients 8 years of age and above in causing stigma and psychiatric issues, particularly anxiety and depression.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Eligibility
Inclusion Criteria:
* Subjects must be aged 8-17 years of age
* Subject must be diagnosed with a chronic skin disease deemed to be severe enough and/or in a visible location that could be stigmatizing as determined by the study doctor
* Subject and parent must both be English speaking with at least one parent/guardian who will complete the questionnaires
* Subject and Parent/Guardian must be able to complete the relevant questionnaires
Exclusion Criteria:
* Children under 8 years of age
* Children with developmental delay and/or a behavioral disorder that would preclude participation in form completion
* Children with a non-cutaneous disorder that is considered by the Study doctor to be stigmatizing
Ages Eligible for Study
8 Years - 17 Years
Genders Eligible for Study
ALL
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Pediatric Dermatology Study
650-723-0636
Not Recruiting
Dermatology Clinical Trials
The Impact of Pediatric Skin Disorders: The "Big" Study
This study leverages the availability of a validated series of instruments to measure the effect of highly visible, chronic skin disorders, including atopic dermatitis (AD), on patients 8 years of age and above in causing stigma and psychiatric issues, particularly anxiety and depression.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Eligibility
Inclusion Criteria:
* Subjects must be aged 8-17 years of age
* Subject must be diagnosed with a chronic skin disease deemed to be severe enough and/or in a visible location that could be stigmatizing as determined by the study doctor
* Subject and parent must both be English speaking with at least one parent/guardian who will complete the questionnaires
* Subject and Parent/Guardian must be able to complete the relevant questionnaires
Exclusion Criteria:
* Children under 8 years of age
* Children with developmental delay and/or a behavioral disorder that would preclude participation in form completion
* Children with a non-cutaneous disorder that is considered by the Study doctor to be stigmatizing
Ages Eligible for Study
8 Years - 17 Years
Genders Eligible for Study
ALL
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Pediatric Dermatology Study
650-723-0636
Not Recruiting
Pediatric Dermatology Clinical Trials
The Impact of Pediatric Skin Disorders: The "Big" Study
This study leverages the availability of a validated series of instruments to measure the effect of highly visible, chronic skin disorders, including atopic dermatitis (AD), on patients 8 years of age and above in causing stigma and psychiatric issues, particularly anxiety and depression.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Eligibility
Inclusion Criteria:
* Subjects must be aged 8-17 years of age
* Subject must be diagnosed with a chronic skin disease deemed to be severe enough and/or in a visible location that could be stigmatizing as determined by the study doctor
* Subject and parent must both be English speaking with at least one parent/guardian who will complete the questionnaires
* Subject and Parent/Guardian must be able to complete the relevant questionnaires
Exclusion Criteria:
* Children under 8 years of age
* Children with developmental delay and/or a behavioral disorder that would preclude participation in form completion
* Children with a non-cutaneous disorder that is considered by the Study doctor to be stigmatizing
Ages Eligible for Study
8 Years - 17 Years
Genders Eligible for Study
ALL
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Pediatric Dermatology Study
650-723-0636
Not Recruiting
The Impact of Pediatric Skin Disorders: The "Big" Study
This study leverages the availability of a validated series of instruments to measure the effect of highly visible, chronic skin disorders, including atopic dermatitis (AD), on patients 8 years of age and above in causing stigma and psychiatric issues, particularly anxiety and depression.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Eligibility
Inclusion Criteria:
* Subjects must be aged 8-17 years of age
* Subject must be diagnosed with a chronic skin disease deemed to be severe enough and/or in a visible location that could be stigmatizing as determined by the study doctor
* Subject and parent must both be English speaking with at least one parent/guardian who will complete the questionnaires
* Subject and Parent/Guardian must be able to complete the relevant questionnaires
Exclusion Criteria:
* Children under 8 years of age
* Children with developmental delay and/or a behavioral disorder that would preclude participation in form completion
* Children with a non-cutaneous disorder that is considered by the Study doctor to be stigmatizing
Ages Eligible for Study
8 Years - 17 Years
Genders Eligible for Study
ALL
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Pediatric Dermatology Study
650-723-0636
Not Recruiting
The Impact of Pediatric Skin Disorders: The "Big" Study
This study leverages the availability of a validated series of instruments to measure the effect of highly visible, chronic skin disorders, including atopic dermatitis (AD), on patients 8 years of age and above in causing stigma and psychiatric issues, particularly anxiety and depression.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Eligibility
Inclusion Criteria:
* Subjects must be aged 8-17 years of age
* Subject must be diagnosed with a chronic skin disease deemed to be severe enough and/or in a visible location that could be stigmatizing as determined by the study doctor
* Subject and parent must both be English speaking with at least one parent/guardian who will complete the questionnaires
* Subject and Parent/Guardian must be able to complete the relevant questionnaires
Exclusion Criteria:
* Children under 8 years of age
* Children with developmental delay and/or a behavioral disorder that would preclude participation in form completion
* Children with a non-cutaneous disorder that is considered by the Study doctor to be stigmatizing
Ages Eligible for Study
8 Years - 17 Years
Genders Eligible for Study
ALL
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Pediatric Dermatology Study
650-723-0636
Not Recruiting